Narvi, Elli
Vaparanta, Katri
Karrila, Anna
Chakroborty, Deepankar http://orcid.org/0000-0002-3458-0205
Knuutila, Sakari
Pulliainen, Arto
Sundvall, Maria
Elenius, Klaus
Article History
Received: 10 May 2018
Accepted: 29 October 2018
First Online: 8 November 2018
Competing Interests
: K.E. has a research agreement with Boehringer Ingelheim, and ownership interest in Abomics, Orion, and Roche.